Human Molecular Genetics, 2000, Vol. 9, No. 12 1721-1727
© 2000 Oxford University Press
The TSC1 gene product, hamartin, negatively regulates cell proliferation
Obstetrics and Gynecology, University of Vienna, Prenatal Diagnosis and Therapy, Währinger Gürtel 18-20, A-1090 Vienna, Austria and 1MGC Department of Clinical Genetics, Erasmus University, 3015GE Rotterdam, The Netherlands
Tuberous sclerosis is an autosomal dominant hereditary disease caused by mutations in either the TSC1 or the TSC2 tumor suppressor gene. The TSC1 gene on chromosome 9q34 encodes a 130 kDa protein named hamartin, and the TSC2 gene on chromosome 16p13.3 codes for tuberin, a 200 kDa protein. Here we show that expression of hamartin, assayed by immunoblot analyses, is high in G0-arrested cells and hamartin is expressed throughout the entire ongoing cell cycle. An interaction of hamartin and tuberin can be detected in every phase of the cell cycle. Ectopic expression of high levels of hamartin attenuates cellular proliferation. We provide evidence that this effect could depend on a coiled-coil region earlier proposed to be involved in binding of hamartin to tuberin. Further investigations revealed that hamartin affects cell proliferation via deregulation of G1 phase. Our data have a clear impact on understanding the role of hamartin during development of this disease.
+ To whom correspondence should be addressed. Tel: +43 1 40400 7847; Fax: +43 1 40400 7848; Email: markus.hengstschlaeger@akh-wien.ac.at
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Rosner and M. Hengstschlager Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1 Hum. Mol. Genet., October 1, 2008; 17(19): 2934 - 2948. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zheng, H. Ding, Z. Lu, Y. Li, Y. Pan, T. Ning, and Y. Ke E3 ubiquitin ligase E6AP-mediated TSC2 turnover in the presence and absence of HPV16 E6. Genes Cells, March 1, 2008; 13(3): 285 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Goncharova, D. A. Goncharov, A. Chisolm, M. S. Spaits, P. N. Lim, G. Cesarone, I. Khavin, O. Tliba, Y. Amrani, R. A. Panettieri Jr., et al. Interferon {beta} Augments Tuberous Sclerosis Complex 2 (TSC2)-Dependent Inhibition of TSC2-Null ELT3 and Human Lymphangioleiomyomatosis-Derived Cell Proliferation Mol. Pharmacol., March 1, 2008; 73(3): 778 - 788. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rosner, A. Freilinger, M. Hanneder, N. Fujita, G. Lubec, T. Tsuruo, and M. Hengstschlager p27Kip1 localization depends on the tumor suppressor protein tuberin Hum. Mol. Genet., July 1, 2007; 16(13): 1541 - 1556. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Sandsmark, H. Zhang, B. Hegedus, C. L. Pelletier, J. D. Weber, and D. H. Gutmann Nucleophosmin Mediates Mammalian Target of Rapamycin-Dependent Actin Cytoskeleton Dynamics and Proliferation in Neurofibromin-Deficient Astrocytes Cancer Res., May 15, 2007; 67(10): 4790 - 4799. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Astrinidis, W. Senapedis, and E. P. Henske Hamartin, the tuberous sclerosis complex 1 gene product, interacts with polo-like kinase 1 in a phosphorylation-dependent manner Hum. Mol. Genet., January 15, 2006; 15(2): 287 - 297. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Zacharek, Y. Xiong, and S. D. Shumway Negative Regulation of TSC1-TSC2 by Mammalian D-Type Cyclins Cancer Res., December 15, 2005; 65(24): 11354 - 11360. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gan, Z. K. Melkoumian, X. Wu, K.-L. Guan, and J.-L. Guan Identification of FIP200 interaction with the TSC1-TSC2 complex and its role in regulation of cell size control J. Cell Biol., August 1, 2005; 170(3): 379 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rosner and M. Hengstschlager Tuberin Binds p27 and Negatively Regulates Its Interaction with the SCF Component Skp2 J. Biol. Chem., November 19, 2004; 279(47): 48707 - 48715. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Astrinidis and E. Petri Henske Aberrant Cellular Differentiation and Migration in Renal and Pulmonary Tuberous Sclerosis Complex J Child Neurol, September 1, 2004; 19(9): 710 - 715. [Abstract] [PDF] |
||||
![]() |
D. K. Scheidenhelm and D. H. Gutmann Mouse Models of Tuberous Sclerosis Complex J Child Neurol, September 1, 2004; 19(9): 726 - 733. [Abstract] [PDF] |
||||
![]() |
M. Karbowniczek, T. Cash, M. Cheung, G. P. Robertson, A. Astrinidis, and E. P. Henske Regulation of B-Raf Kinase Activity by Tuberin and Rheb Is Mammalian Target of Rapamycin (mTOR)-independent J. Biol. Chem., July 16, 2004; 279(29): 29930 - 29937. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yu, A. Astrinidis, S. Howard, and E. P. Henske Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L694 - L700. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jozwiak, D. Kwiatkowski, K. Kotulska, M. Larysz-Brysz, J. Lewin-Kowalik, W. Grajkowska, and M. Roszkowski Tuberin and Hamartin Expression Is Reduced in the Majority of Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex Consistent With a Two-Hit Model of Pathogenesis J Child Neurol, February 1, 2004; 19(2): 102 - 106. [Abstract] [PDF] |
||||
![]() |
A. Astrinidis, W. Senapedis, T. R. Coleman, and E. P. Henske Cell Cycle-regulated Phosphorylation of Hamartin, the Product of the Tuberous Sclerosis Complex 1 Gene, by Cyclin-dependent Kinase 1/Cyclin B J. Biol. Chem., December 19, 2003; 278(51): 51372 - 51379. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Karbowniczek, A. Astrinidis, B. R. Balsara, J. R. Testa, J. H. Lium, T. V. Colby, F. X. McCormack, and E. P. Henske Recurrent Lymphangiomyomatosis after Transplantation: Genetic Analyses Reveal a Metastatic Mechanism Am. J. Respir. Crit. Care Med., April 1, 2003; 167(7): 976 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Mak, K.-I. Takemaru, H. L. Kenerson, R. T. Moon, and R. S. Yeung The Tuberin-Hamartin Complex Negatively Regulates beta -Catenin Signaling Activity J. Biol. Chem., February 14, 2003; 278(8): 5947 - 5951. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Tee, D. C. Fingar, B. D. Manning, D. J. Kwiatkowski, L. C. Cantley, and J. Blenis Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling PNAS, October 15, 2002; 99(21): 13571 - 13576. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nellist, M. A. Goedbloed, C. de Winter, B. Verhaaf, A. Jankie, A. J. J. Reuser, A. M. W. van den Ouweland, P. van der Sluijs, and D. J. J. Halley Identification and Characterization of the Interaction between Tuberin and 14-3-3zeta J. Biol. Chem., October 11, 2002; 277(42): 39417 - 39424. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Khare, A Astrinidis, W Senapedis, P D Adams, and E P. Henske Expression of wild type and mutant TSC2, but not TSC1, causes an increase in the G1 fraction of the cell cycle in HEK293 cells J. Med. Genet., September 1, 2002; 39(9): 676 - 680. [Full Text] [PDF] |
||||
![]() |
A. K. Hodges, S. Li, J. Maynard, L. Parry, R. Braverman, J. P. Cheadle, J. E. DeClue, and J. R. Sampson Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin Hum. Mol. Genet., December 1, 2001; 10(25): 2899 - 2905. [Abstract] [Full Text] [PDF] |
||||










